Oncomir miR17, Tumour Suppressor miR146a, miR302d, and Oncogene miR19B Expressions in Hepatoblastoma Patients

Ecevit, C. O.Aktas, S.Yildirim, H. T.Demirag, B.Erbay, A.Karaca, I.Celik, A.Demir, B.Ercetin, P.Olgun, N.2019-10-272019-10-2720161545-50091545-5017https://hdl.handle.net/11454/33317eninfo:eu-repo/semantics/closedAccessOncomir miR17, Tumour Suppressor miR146a, miR302d, and Oncogene miR19B Expressions in Hepatoblastoma PatientsConference Object63S237S237WOS:000384818801416Q1